The University of Utah Molecular Medicine Program (U2M2) is the key multidepartmental and interdisciplinary engine for clinical departments. U2M2 investigators have primary appointments in clinical departments and lead research programs that advance translational science by catalyzing the development, testing, and implementation of new diagnostics and therapeutics for a variety of human diseases and conditions. U2M2 is located in the Eccles Institute of Human Genetics alongside the Department of Human Genetics. U2M2 provides core faculty that lead the Research Education Core of the CTSA, the MD-PhD program, the Summer Medical Research program, the Med to Grad Program, the NIH Heart Failure Clinical Research Network and the Metabolism Interest Group. U2M2 directs the T-32 in Cardiovascular Research and the T-32 in Metabolic Disease. These T-32s are integrated with the CTSA, MD-PhD program and the Med to Grad Program and, as such, serve as templates for T-32s across the clinical and basic science departments.
Molecular Medicine’s Diversity Statement
The University of Utah Molecular Medicine Program is committed to equity, diversity and inclusion. We believe that an inclusive environment that supports diversity and equity amongst our faculty, trainees and staff helps drive scientific innovation in early translational research. Collaboration within and beyond Molecular Medicine brings differing viewpoints to solve challenges and advance human health. We embrace all members of our community and respect and celebrate their diverse backgrounds with respect to national origin, race, ethnicity, religion, sexual orientation, gender identity/expression, age, socioeconomic background, or status as a veteran or person with disabilities.